Maria Wriedt Jakobsen

Maria Wriedt Jakobsen has a diverse work experience in the field of clinical operations and trial management. Maria Wriedt is currently working as the Director of Clinical Operations at Minervax ApS since February 2023. Prior to this, they worked as an independent consultant at Wriedt Consulting, specializing in project and trial management, starting from July 2019.

Maria also held the position of Director of Clinical Operations at Evaxion Biotech A/S from March 2020 to April 2021 and at PharmaIT from August 2019 to April 2020. Before that, they worked as a Senior Clinical Trial Manager at Zealand Pharma A/S from August 2018 to August 2019 and as a Senior Clinical Project Manager at LEO Pharma from February 2017 to August 2018.

Maria gained valuable experience as an International Trial Manager at Novo Nordisk from September 2012 to February 2017, overseeing all aspects of clinical trials and non-interventional post-authorization safety studies. Maria Wriedt was responsible for conducting meetings, budget reviews, vendor set-up, and leading study group meetings.

Furthermore, Maria worked as an International Clinical Trial Coordinator at Ferring Pharmaceuticals A/S from September 2010 to September 2012 and as a Senior Clinical Research Associate at Smerud Medical Research from November 2007 to September 2010.

Maria started their career as a Cand Pharm at 1-800-Pharmacy from November 2006 to November 2007. Overall, their work experience showcases their expertise in clinical operations, project management, and trial coordination in the pharmaceutical industry.

Maria Wriedt Jakobsen completed their upper secondary high school education at Niels Steensen Gymnasium from 1996 to 1999. Maria Wriedt then pursued a Master of Science in Pharmacy at Danmarks Farmaceutiske Universitet from 2000 to 2006. No specific field of study was provided for either educational experience.